Literature DB >> 9196426

K+ channel opening: a new drug principle in cardiovascular medicine.

I Gussak, F Bjerregaard.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9196426      PMCID: PMC484778          DOI: 10.1136/hrt.77.5.487

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  11 in total

1.  Role of K+ channel activators in cardiac electrophysiology and arrhythmias.

Authors:  C Antzelevitch; J M Di Diego
Journal:  Circulation       Date:  1992-04       Impact factor: 29.690

Review 2.  K+ channel opening: a new drug principle in cardiovascular medicine.

Authors:  J E Nielsen-Kudsk; S Boesgaard; J Aldershvile
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

Review 3.  Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection?

Authors:  D J Hearse
Journal:  Cardiovasc Res       Date:  1995-07       Impact factor: 10.787

4.  Potassium channel openers are likely to be proarrhythmic in the diseased human heart.

Authors:  S C Black; B R Lucchesi
Journal:  Cardiovasc Res       Date:  1994-06       Impact factor: 10.787

5.  Potassium channel openers are unlikely to be proarrhythmic in the diseased human heart.

Authors:  A J D'Alonzo; G J Grover
Journal:  Cardiovasc Res       Date:  1994-06       Impact factor: 10.787

Review 6.  Electrophysiological effects of ATP sensitive potassium channel modulation: implications for arrhythmogenesis.

Authors:  A A Wilde; M J Janse
Journal:  Cardiovasc Res       Date:  1994-01       Impact factor: 10.787

7.  Role of ATP-sensitive K+ channel on ECG ST segment elevation during a bout of myocardial ischemia. A study on epicardial mapping in dogs.

Authors:  I Kubota; M Yamaki; T Shibata; E Ikeno; Y Hosoya; H Tomoike
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

8.  Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.

Authors:  Z Yao; G J Gross
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

9.  Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.

Authors:  S A Rees; K Tsuchihashi; D J Hearse; M J Curtis
Journal:  J Cardiovasc Pharmacol       Date:  1993-09       Impact factor: 3.105

10.  Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential duration.

Authors:  G J Grover; A J D'Alonzo; C S Parham; R B Darbenzio
Journal:  J Cardiovasc Pharmacol       Date:  1995-07       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.